CIK 0001280784
- Large accelerated filer
Hercules Capital, Inc.
Sign in to watch- Tickers
- HCXY HTGC
- Exchange
- NYSE
- FY end
- Dec 31
- Incorporated
- MD
- Entity type
- Operating
- EIN
- 743113410
- Phone
- +1 650-289-3060
- Business address
- 1 NORTH B STREET, SUITE 2000, SAN MATEO, CA, 94401
- Former names
- HERCULES TECHNOLOGY GROWTH CAPITAL INC
Securities
- HCXY 6.25% Notes due 2033 NYSE
- HTGC Common Stock NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-20 | Theodosopoulos Nikos Director | Grant or award | +3,030 | $19.80 | $60K | 4,005 |
| 2024-06-20 | CROWELL GAYLE A Director | Grant or award | +3,030 | $19.80 | $60K | 52,874 |
| 2024-06-20 | Fallon Thomas J Director | Grant or award | +3,030 | $19.80 | $60K | 8,096 |
| 2024-06-20 | Fallon Thomas J Director | Returned to the company | −149 | 7,947 | ||
| 2024-06-20 | Fallon Thomas J Director | Grant or award | +149 | 85,519 | ||
| 2024-06-20 | BADAVAS ROBERT P Director | Exercise or conversion | +13,300 | $16.34 | $217K | 17,534 |
| 2024-06-20 | BADAVAS ROBERT P Director | Sale | −13,300 | $19.69 | $262K | 4,234 |
| 2024-06-20 | BADAVAS ROBERT P Director | Exercise or conversion · Stock Option (Right to Buy) | −13,300 | 0 | ||
| 2024-06-20 | BADAVAS ROBERT P Director | Exercise or conversion | +13,300 | $16.34 | $217K | 17,534 |
| 2024-06-20 | BADAVAS ROBERT P Director | Sale | −13,300 | $19.69 | $262K | 4,234 |
| 2024-06-20 | BADAVAS ROBERT P Director | Exercise or conversion · Stock Option (Right to Buy) | −13,300 | 0 | ||
| 2024-06-18 | BADAVAS ROBERT P Director | Exercise or conversion | +1,700 | $16.34 | $28K | 5,934 |
| 2024-06-18 | BADAVAS ROBERT P Director | Sale | −1,700 | $19.60 | $33K | 4,234 |
| 2024-06-18 | BADAVAS ROBERT P Director | Exercise or conversion · Stock Option (Right to Buy) | −1,700 | 13,300 | ||
| 2024-06-18 | BADAVAS ROBERT P Director | Exercise or conversion | +1,700 | $16.34 | $28K | 5,934 |
| 2024-06-18 | BADAVAS ROBERT P Director | Sale | −1,700 | $19.60 | $33K | 4,234 |
| 2024-06-18 | BADAVAS ROBERT P Director | Exercise or conversion · Stock Option (Right to Buy) | −1,700 | 13,300 | ||
| 2024-04-11 | Meyer Seth H Chief Financial Officer | Shares withheld for taxes | −6,708 | $18.41 | $123K | 348,919 |
| 2024-04-11 | Follmann Christian Chief Operating Officer | Shares withheld for taxes | −1,251 | $18.41 | $23K | 96,052 |
| 2024-04-11 | Botelho Kiersten Zaza General Counsel & CCO | Shares withheld for taxes | −822 | $18.41 | $15K | 49,029 |
Page 9 of 15 · 292 trades